Communiqués Centogene N.V.

Actions

CNTG

NL0014040206

Marché Fermé - Nasdaq Autres places de cotation 22:30:00 12/06/2024			Varia. 5j.	Varia. 1 janv.
0,375 ^USD	+2,74 %		+1,35 %	-68,75 %

16/05	La série de données économiques à venir stimule les fonds négociés en bourse et les contrats à terme sur actions avant la cloche de jeudi	MT
16/05	Les plus fortes hausses du prémarché	MT

Communiqués

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Centogene N : Minutes of the 2024 Annual General Meeting of Shareholders - Centogene N.V.	31/05	PU
CENTOGENE Announces Adoption of All Resolutions Tabled at 2024 Annual General Meeting	31/05	GL
Centogene N : KSA RECEIVABLES TRANSFER AGREEMENT - Form 6-K	15/05	PU
CENTOGENE Reports Full Year 2023 Financial Results and Recent Business Highlights	15/05	GL
CENTOGENE Secures Approx. $20 Million to Strengthen Cash Position	15/05	GL
Centogene N : Voting Proxy AGM 2024	15/05	PU
Centogene N : Convening Notice and Agenda (incl. explanatory notes) (AGM 2024)	15/05	PU
CENTOGENE and Evotec Discover Promising New Molecule to Treat Gaucher Disease	14/05	GL
CENTOGENE Biodatabank Grows to Incorporate Disease Insights From Over 850,000 Diverse Patients	13/05	AQ
CENTOGENE Biodatabank Grows to Incorporate Disease Insights From Over 850,000 Diverse Patients	10/05	GL
Centogene N : Form 6-K	02/05	PU
CENTOGENE Receives Nasdaq Non-Compliance Notice	02/04	GL
CENTOGENE Extends Strategic Partnership With Takeda to Continue Providing Access to Genetic Testing for Patients With Lysosomal Storage Disorders	19/03	GL
CENTOGENE Collaborates on Research Published in Science Showing Immunopathological Landscape of Human Pre-TCRα Deficiency	29/02	GL
CENTOGENE Announces Receipt of Nasdaq Notice of Delisting and Intention to Request a Hearing	28/02	GL
CENTOGENE Explores Strategic Alternatives	28/02	GL
CENTOGENE and the Laboratory of Human Genetics of Infectious Diseases at Institut Imagine Announce Rare Disease Research Collaboration	25/01	GL
CENTOGENE Receives French Research Tax Credit Accreditation	24/01	GL
CENTOGENE and The Michael J. Fox Foundation Announce Research Project to Validate Genetic Risk Factors of Parkinson’s Disease Using Multiomics	23/01	GL
CENTOGENE Announces Preliminary Full Year 2023 Revenue	18/01	GL

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Centogene N.V.

Actions

CNTG

NL0014040206

Communiqués

Filtres